PDCD1 and neoplasm: To validate the anti-tumor function of Exo-PD-1 in vivo, Exo-mCon or Exo-mPD-1 isolated from mouse T cells was then injected intraperitoneally to PY8119 tumor-bearing mice according to the study design.